evolv
respiratori
renal
failur
without
rhabdomyolysi
place
mechan
ventil
hemodialysi
clinic
outcom
posit
day
hospit
stay
addit
patient
clinic
stabl
month
followup
recent
advanc
critic
care
medicin
cystic
fibrosi
treatment
surviv
advanc
pulmonari
diseas
cystic
fibrosi
present
new
question
potenti
problem
still
formul
adhes
particular
influenza
viru
associ
sever
exacerb
lead
prolong
hospit
predispos
bacteri
infect
caus
diseas
progress
mark
loss
lung
function
studi
aim
report
case
season
influenza
occur
june
patient
cf
receiv
trival
influenza
vaccin
april
develop
acut
respiratori
failur
acut
renal
failur
without
rhabdomyolysi
infect
male
caucasian
diagnos
cf
sinc
age
year
old
homozyg
mutat
exocrin
pancreat
insuffici
cfrelat
diabet
mellitu
obstruct
azoospermia
chronic
lung
diseas
bronchiectasi
chronic
pseudomona
aeruginosa
infect
prior
spirometri
sever
airflow
limit
reduct
forc
vital
capac
present
tabl
peripher
oxygen
satur
spo
ambient
air
cardiac
auscult
reveal
regular
twobeat
rhythm
lung
auscult
indic
vesicular
murmur
present
lung
field
diffus
fine
coars
rale
patient
abdomen
without
chang
extrem
well
perfus
initi
laboratori
test
show
hematocrit
hemoglobin
leukocytesmm
bandshap
segment
monocyt
monocyt
metamyelocyt
urea
creatinin
prior
potassium
lactat
creactiv
protein
creatin
phosphokinas
normal
common
urin
test
result
reveal
citrin
yellow
urin
red
blood
neg
hemoglobin
arteri
blood
ga
test
reveal
lmin
oxygen
per
extern
nasal
cathet
ph
partial
carbon
dioxid
pressur
paco
bicarbon
partial
oxygen
pressur
pao
oxygen
satur
patient
chest
xray
shown
figur
receiv
volum
replac
salin
correct
system
arteri
pressur
antibiot
coverag
piperacillintazobactam
intraven
tobramycin
initi
base
sensit
test
last
bacteriolog
examin
sputum
still
within
first
hour
admiss
noninvas
june
admit
emerg
room
hospit
de
de
porto
alegr
continu
fever
day
sever
cough
increas
volum
purul
expector
prostrat
headach
progress
dyspnea
deni
myalgia
report
wife
son
two
famili
member
previous
respiratori
symptom
high
fever
myalgia
last
week
regularli
taken
flu
vaccin
receiv
trival
vaccin
april
physic
examin
patient
blood
pressur
heart
rate
respiratori
rate
cyanot
accessori
breath
muscl
prolong
expiratori
time
ventil
niv
antivir
coverag
oseltamivir
initi
hour
hospit
evolv
respiratori
failur
transfer
intens
care
unit
icu
requir
orotrach
intub
mechan
ventil
initi
patient
ventil
control
pressur
inspir
oxygen
fraction
fio
posit
endexpiratori
pressur
peep
pressur
peep
respiratori
rate
breathsminut
tidal
volum
pao
fio
fulfil
criteria
acut
respiratori
distress
syndrom
also
worsen
renal
function
increas
creatinin
oliguria
dialysi
treatment
initi
continu
hemodialysi
antibiot
scheme
modifi
ciprofloxacin
vancomycin
maintain
piperacillintazobactam
fifth
day
hospit
viral
investig
perform
via
polymeras
chain
reaction
nasopharyng
secret
sampl
collect
time
admiss
test
posit
influenza
investig
univers
gene
influenza
strain
posit
swine
line
gene
amplif
hemagglutinin
viru
nucleoprotein
neg
use
oseltamivir
maintain
day
favor
evolut
day
hospit
admiss
patient
could
extub
place
niv
intermitt
dialysi
discharg
icu
ward
week
discharg
icu
experienc
sudden
worsen
return
icu
manag
niv
stay
angiotomographi
thorax
exclud
possibl
pulmonari
embol
antibiot
scheme
modifi
meropenem
polymyxin
b
new
sputum
cultur
evidenc
multiresist
p
aeruginosa
experienc
progress
clinic
improv
respiratori
condit
resolut
acut
renal
failur
hospit
discharg
occur
day
admiss
discharg
receiv
standard
treatment
cf
continu
home
oxygen
therapi
refer
pulmonari
rehabilit
program
sinc
event
requir
new
hospit
stay
patient
last
spirometri
present
tabl
decemb
month
event
patient
pulmonari
rehabilit
oxygen
therapi
exercis
night
refer
lung
transplant
yet
activ
list
due
clinic
stabil
recent
advanc
cf
treatment
intens
medicin
patient
advanc
lung
diseas
live
longer
present
case
report
show
evolut
adult
patient
previou
sever
lung
diseas
stabl
acut
respiratori
failur
sepsi
acut
renal
failur
trigger
influenza
good
clinic
outcom
intens
support
document
clinic
stabil
month
evolut
epidemiolog
data
influenza
show
vaccin
effect
prevent
influenza
visit
age
group
specif
influenza
influenza
b
despit
low
effect
influenza
vaccin
influenza
vaccin
recommend
individu
age
month
antivir
medic
especi
oseltamivir
use
adjunct
measur
vaccin
control
influenza
physician
consid
influenza
activ
widespread
diagnosi
alway
consid
case
sever
acut
respiratori
syndrom
present
case
identif
influenza
viru
made
via
molecular
biolog
test
nasopharynx
aspir
emphas
laboratori
identifi
presenc
influenza
exclud
presenc
influenza
viru
howev
subtyp
viru
perform
accord
epidemiolog
data
depart
health
rio
grand
sul
ministri
health
brazil
viru
largest
circul
influenza
thu
viral
identif
report
case
like
correspond
influenza
explain
diseas
despit
adequ
patient
vaccin
coverag
evid
treat
sever
influenza
limit
therefor
recommend
rout
administr
dosag
time
use
follow
gener
guidelin
administr
oseltamivir
via
nasogastr
nasoenter
rout
seem
guarante
adequ
system
absorpt
major
case
sever
influenza
standard
oseltamivir
regimen
dose
everi
hour
recommend
howev
although
definit
evid
recommend
depend
clinic
judgment
treatment
time
may
prolong
sever
case
dose
may
also
doubl
everi
hour
present
case
treatment
initi
earli
oral
admiss
subsequ
maintain
nasoenter
rout
usual
dose
time
renal
involv
individu
infect
influenza
uncommon
acut
renal
failur
commonli
report
critic
ill
patient
report
renal
failur
case
influenza
rare
pathogen
mechan
develop
renal
injuri
influenza
viru
infect
fulli
understood
potenti
caus
rhabdomyolysi
direct
renal
damag
viru
sepsisrel
renal
hypoperfus
dissemin
intravascular
coagul
syndrom
among
rhabdomyolysi
frequent
report
caus
report
case
evid
rhabdomyolysi
absenc
myalgia
urin
dark
hematuria
reactant
tape
creatin
phosphokinas
normal
like
mechan
renal
injuri
sepsi
renal
hypoperfus
month
followup
evolut
present
case
cystic
fibrosi
advanc
lung
diseas
complic
infect
influenza
respiratori
sepsi
acut
respiratori
failur
acut
renal
failur
favor
